Bitcoin pioneer Charlie Shrem peels back the layers on the lives and backgrounds of the world's most impactful innovators. Centering around intimate narratives, Shrem uncovers a detailed, previously unspoken story of the genesis and evolution of bitcoin, cryptocurrency, artificial intelligence, and the web3 movements. Join Shrem as he journeys through the uncharted territories of tech revolutions, revealing the human side of the stories that shaped the digital world we live in today.
…
continue reading
Контент предоставлен Proactive Investors. Весь контент подкастов, включая эпизоды, графику и описания подкастов, загружается и предоставляется непосредственно компанией Proactive Investors или ее партнером по платформе подкастов. Если вы считаете, что кто-то использует вашу работу, защищенную авторским правом, без вашего разрешения, вы можете выполнить процедуру, описанную здесь https://ru.player.fm/legal.
Player FM - приложение для подкастов
Работайте офлайн с приложением Player FM !
Работайте офлайн с приложением Player FM !
Tonix Pharmaceuticals CEO Discusses New Long Covid Report and Its Implications
MP3•Главная эпизода
Manage episode 432634901 series 2891889
Контент предоставлен Proactive Investors. Весь контент подкастов, включая эпизоды, графику и описания подкастов, загружается и предоставляется непосредственно компанией Proactive Investors или ее партнером по платформе подкастов. Если вы считаете, что кто-то использует вашу работу, защищенную авторским правом, без вашего разрешения, вы можете выполнить процедуру, описанную здесь https://ru.player.fm/legal.
Dr. Seth Lederman, CEO of Tonix Pharmaceuticals, recently joined Steve Darling from Proactive to discuss the implications of a groundbreaking report from the US National Academies of Sciences, Engineering, and Medicine on long Covid. The report defines long Covid as a chronic condition encompassing multiple diagnosable disorders, thus paving the way for better understanding and treatment approaches. A particularly significant finding in the report is the acknowledgment that fibromyalgia can now be diagnosed in patients with long Covid, which eliminates previous diagnostic uncertainties. This development is especially beneficial for Tonix Pharmaceuticals, as the company is advancing TNX-102 SL, a drug designed to treat fibromyalgia. Dr. Lederman pointed out that this new diagnostic clarity could substantially broaden the addressable market for TNX-102 SL, which already targets approximately 10 million American adults diagnosed with fibromyalgia. Tonix Pharmaceuticals is in the final stages of developing TNX-102 SL, having received FDA Fast Track designation in recognition of its significant potential. The company has completed two statistically significant studies and is preparing a new drug application for submission. Dr. Lederman, who has nearly 30 years of experience researching fibromyalgia, emphasized the potential impact of this report on the estimated 14 million Americans suffering from long Covid. This new diagnostic criterion could enable these individuals to access effective treatments for fibromyalgia, representing a significant advancement in patient care. #proactiveinvestors #tonixpharmaceuticalsholdingcorp #nasdaq #tnxp #TonixPharmaceuticals, #SethLederman, #LongCovid, #Fibromyalgia, #NationalAcademies, #USScience, #TNX102SL, #DrugDevelopment, #FDA, #FastTrack, #Pharmaceuticals, #Health, #MedicalResearch, #Covid19, #ChronicIllness, #Medicine, #Healthcare, #ScientificResearch, #NewDrugApplication, #FibromyalgiaTreatment#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
…
continue reading
621 эпизодов
MP3•Главная эпизода
Manage episode 432634901 series 2891889
Контент предоставлен Proactive Investors. Весь контент подкастов, включая эпизоды, графику и описания подкастов, загружается и предоставляется непосредственно компанией Proactive Investors или ее партнером по платформе подкастов. Если вы считаете, что кто-то использует вашу работу, защищенную авторским правом, без вашего разрешения, вы можете выполнить процедуру, описанную здесь https://ru.player.fm/legal.
Dr. Seth Lederman, CEO of Tonix Pharmaceuticals, recently joined Steve Darling from Proactive to discuss the implications of a groundbreaking report from the US National Academies of Sciences, Engineering, and Medicine on long Covid. The report defines long Covid as a chronic condition encompassing multiple diagnosable disorders, thus paving the way for better understanding and treatment approaches. A particularly significant finding in the report is the acknowledgment that fibromyalgia can now be diagnosed in patients with long Covid, which eliminates previous diagnostic uncertainties. This development is especially beneficial for Tonix Pharmaceuticals, as the company is advancing TNX-102 SL, a drug designed to treat fibromyalgia. Dr. Lederman pointed out that this new diagnostic clarity could substantially broaden the addressable market for TNX-102 SL, which already targets approximately 10 million American adults diagnosed with fibromyalgia. Tonix Pharmaceuticals is in the final stages of developing TNX-102 SL, having received FDA Fast Track designation in recognition of its significant potential. The company has completed two statistically significant studies and is preparing a new drug application for submission. Dr. Lederman, who has nearly 30 years of experience researching fibromyalgia, emphasized the potential impact of this report on the estimated 14 million Americans suffering from long Covid. This new diagnostic criterion could enable these individuals to access effective treatments for fibromyalgia, representing a significant advancement in patient care. #proactiveinvestors #tonixpharmaceuticalsholdingcorp #nasdaq #tnxp #TonixPharmaceuticals, #SethLederman, #LongCovid, #Fibromyalgia, #NationalAcademies, #USScience, #TNX102SL, #DrugDevelopment, #FDA, #FastTrack, #Pharmaceuticals, #Health, #MedicalResearch, #Covid19, #ChronicIllness, #Medicine, #Healthcare, #ScientificResearch, #NewDrugApplication, #FibromyalgiaTreatment#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
…
continue reading
621 эпизодов
Alle afleveringen
×Добро пожаловать в Player FM!
Player FM сканирует Интернет в поисках высококачественных подкастов, чтобы вы могли наслаждаться ими прямо сейчас. Это лучшее приложение для подкастов, которое работает на Android, iPhone и веб-странице. Зарегистрируйтесь, чтобы синхронизировать подписки на разных устройствах.